Growth hormone (GH) replacement therapy in adults with GH deficiency is still a challenge
for the clinical endocrinologist and its implementation has still numerous difficulties and …

The adult growth hormone deficiency (GHD) syndrome is a well-defined clinical entity.
Although the symptoms of GHD are not age specific, their relative importance differs …

Childhood survivors of cancer are prone to a number of adverse sequelae related to the
therapeutic interventions undertaken to achieve remission. The endocrine system is …

OBJECTIVE: To examine the impact of adolescent growth hormone deficiency (GHD) on
circulating adiponectin levels and the relation between adiponectin, fasting insulin, plasma …

Background/Aims: Studies are lacking regarding the timing of peak growth hormone (PGH)
response. We aim to elucidate the timing of PGH response to arginine and levodopa (A-LD) …

OBJECTIVE: Growth hormone deficiency (GHD) in adults is associated with abnormal body
composition, altered lipid profile, reduced quality of life and osteoporosis. Replacement with …

Growth hormone (GH) has been available for more than 4 decades for the treatment of GH
deficiency. Initially, GH was extracted from the pituitary glands of human cadavers, but its …

Objective Systematic collections of neuroimaging data are nonexistent in brain tumour
survivors treated with adult growth hormone replacement therapy (AGHRT). We present our …

Recombinant human GH has been licensed for use in adult patients with GH deficiency
(GHD) for over 15 years. Early weight-and surface area-based dosing regimens were …

Objective: To determine whether postprandial lipids, coagulation factors and homocysteine
levels are abnormal in young growth hormone (GH)-deficient (GHD) adolescents. Methods …